Wei, H., Cui, C., Cui, X., Liu, Y., & Li, D. (2021). Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China. BMC Health Serv Res.
Stile di citazione ChicagoWei, Hongtao, Can Cui, Xiangli Cui, Yi Liu, e Dandan Li. "Cost‐effectiveness Analysis of Dabigatran, Rivaroxaban and Warfarin in the Prevention of Stroke in Patients With Atrial Fibrillation in China." BMC Health Serv Res 2021.
Citazione MLAWei, Hongtao, et al. "Cost‐effectiveness Analysis of Dabigatran, Rivaroxaban and Warfarin in the Prevention of Stroke in Patients With Atrial Fibrillation in China." BMC Health Serv Res 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.